Placenta Polypeptide

Unknown Manufacturer

Indications

用于细胞免疫功能降低或失调引起的疾病、术后愈合、病毒性感染引起的疾病及各种原因所致的白细胞减少症。

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Placenta polypeptide injection
Applicant: ZHENG YONGGANGPriority: 2017
CN
Preparation method of placenta polypeptide injection
Applicant: WEIHAI HENGJI WEIYE INFORMATION TECH DEV CO LTDPriority: 2016
CN
Low-molecular-weight polypeptide extracted from placenta
Applicant: AESTHETIC INTERNAT HOLDINGSCHAIN GROUPPriority: 2014
CN
Lamb placenta polypeptide and preparation method thereof
Applicant: HUZHOU KANGHAISI BIOLOG TECHNOLOGY CO LTDPriority: 2011
CN
Chimeral polypeptide composition for cross-placenta delivery
Applicant: UNIV SAINT LOUISPriority: 2007
US
Improved preparation method of placenta polypeptide for injection
Applicant: CHINA INST FOR RADIATION PROTPriority: 2012
CN
Method for extracting antioxidant polypeptide from human placenta blood
Applicant: INNER MONGOLIA YINHONG STEM CELL LIFE SCIENCE AND TECH INVESTMENT CO LTDPriority: 2021
CN
Method for preparing physiological active polypeptide of deer placenta
Applicant: ZHENG BINPriority: 2006
CN